{
    "clinical_study": {
        "@rank": "25048", 
        "arm_group": [
            {
                "arm_group_label": "Probiotics", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "To demonstrate benefit and tolerability of a probiotic product in infants with abdominal\n      discomfort."
        }, 
        "brief_title": "Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort", 
        "condition": "Abdominal Discomfort", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female singleton\n\n          -  \u2265 2 weeks and \u2264 12 weeks of age\n\n          -  Exclusively breastfed at screening\n\n          -  Abdominal discomfort (infant colic) in the week prior to enrollment, according to the\n             statement of the parent(s) and/or guardian(s)\n\n          -  Episodes of fussy crying that lasted at least 3 hours a day for at least 3 days in\n             the 7 days prior to enrollment, according to the statement of the parent(s) and/or\n             guardian(s)\n\n          -  Voluntary, written informed consent of the parent(s) and/or guardian(s) to\n             participate in the study\n\n          -  Born at full term (37-42 after last menstruation period)\n\n          -  Birth weight: 2500 - 4500 g\n\n          -  Weight-for-age \u2265 3th and \u2264 97th percentile according to WHO growth tables / charts\n\n          -  Apparently healthy at birth (Apgar \u2265 8) and at screening visit\n\n          -  No major complications during pregnancy or at birth\n\n          -  Mother 19-45 years of age at childbirth\n\n          -  Ability of parent(s) and/or guardian(s) to attend visits, interviews and willingness\n             to fill out questionnaires\n\n        Exclusion Criteria:\n\n          -  Intolerance to investigational product/its ingredients\n\n          -  Severe medical condition or illness, congenital abnormality\n\n          -  Gastrointestinal disorders (e.g. reflux esophagitis)\n\n          -  Intake of probiotics and/or antibiotics in the week preceding recruitment and during\n             the study\n\n          -  Formula feeding at screening/randomisation\n\n          -  Allergy or atopic disease (family history)\n\n          -  Participation in another study\n\n          -  Mother's health condition that may interfere with her ability to take care of her\n             infant\n\n          -  Mother affected by hepatitis B, HIV or Guillain-Barr\u00e9 Syndrom\n\n          -  Use of antibiotics by the mother in the week"
            }, 
            "gender": "Both", 
            "maximum_age": "12 Weeks", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01893814", 
            "org_study_id": "PAB/029911"
        }, 
        "intervention": [
            {
                "arm_group_label": "Probiotics", 
                "intervention_name": "Probiotics", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "Control", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Berlin", 
                    "country": "Germany", 
                    "zip": "13353"
                }, 
                "name": "Charit\u00e9 Virchow Hospital"
            }, 
            "investigator": {
                "last_name": "Andrea Loui, Dr Med", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "andrea.loui@charite.de", 
            "last_name": "Andrea Loui, Dr Med", 
            "phone": "+49 30 450 566463"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Reduction of abdominal discomfort as assessed by comparison of crying time", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01893814"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Probi AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Probi AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}